D. E. Shaw & Co. Inc. Purchases 28,493 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

D. E. Shaw & Co. Inc. boosted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 13.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 247,074 shares of the medical instruments supplier's stock after buying an additional 28,493 shares during the period. D. E. Shaw & Co. Inc. owned approximately 0.61% of AngioDynamics worth $2,263,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of ANGO. Divisadero Street Capital Management LP purchased a new stake in AngioDynamics during the 4th quarter valued at $4,714,000. Segall Bryant & Hamill LLC raised its holdings in AngioDynamics by 55.3% during the 4th quarter. Segall Bryant & Hamill LLC now owns 1,415,156 shares of the medical instruments supplier's stock valued at $12,963,000 after buying an additional 503,713 shares during the period. Marshall Wace LLP increased its stake in AngioDynamics by 1,335.1% in the fourth quarter. Marshall Wace LLP now owns 476,824 shares of the medical instruments supplier's stock worth $4,368,000 after purchasing an additional 443,598 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in AngioDynamics by 293.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 352,544 shares of the medical instruments supplier's stock worth $3,229,000 after purchasing an additional 263,034 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in AngioDynamics by 46.0% in the fourth quarter. JPMorgan Chase & Co. now owns 807,483 shares of the medical instruments supplier's stock worth $7,397,000 after purchasing an additional 254,322 shares during the period. Hedge funds and other institutional investors own 89.43% of the company's stock.

AngioDynamics Stock Performance

ANGO stock traded up $0.04 during midday trading on Friday, reaching $9.45. The company's stock had a trading volume of 390,130 shares, compared to its average volume of 552,362. The stock has a fifty day simple moving average of $9.47 and a two-hundred day simple moving average of $9.46. AngioDynamics, Inc. has a 1 year low of $5.47 and a 1 year high of $13.50. The firm has a market capitalization of $383.74 million, a price-to-earnings ratio of -1.68 and a beta of 0.58.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last posted its quarterly earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. The business had revenue of $72.00 million for the quarter, compared to the consensus estimate of $70.30 million. The business's revenue was down 4.3% compared to the same quarter last year. As a group, analysts forecast that AngioDynamics, Inc. will post -0.37 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a "buy" rating and issued a $16.00 target price (up previously from $15.00) on shares of AngioDynamics in a research note on Monday, April 7th.

AngioDynamics Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.